In Weight Loss Battle, Novo and Lilly Face Growing Offensive from Licensed Copies
SHANGHAI – As Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) expand sales of their popular diabetes and weight-loss […]
In Weight Loss Battle, Novo and Lilly Face Growing Offensive from Licensed Copies Read More »